Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?

Richard E. Kennedy, Gary R. Cutter, Guoqiao Wang, Lon S. Schneider

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?'. Together they form a unique fingerprint.

Medicine & Life Sciences